34 related articles for article (PubMed ID: 30865318)
1. Proton pump inhibitors and dementia risk: Evidence from a cohort study using linked routinely collected national health data in Wales, UK.
Cooksey R; Kennedy J; Dennis MS; Escott-Price V; Lyons RA; Seaborne M; Brophy S
PLoS One; 2020; 15(9):e0237676. PubMed ID: 32946449
[TBL] [Abstract][Full Text] [Related]
2. Increased mortality in patients with hematologic malignancies treated with proton pump inhibitors: a nationwide cohort study.
Vilmar A; Dehlendorff C; Friis S; Jäättelä M; Tvingsholm S; Frederiksen H
Leuk Lymphoma; 2023; 64(8):1451-1457. PubMed ID: 37293759
[TBL] [Abstract][Full Text] [Related]
3. Proton pump inhibitors and risk of severe COVID-19 in older people.
Gramont B; Fayolle S; Beltramin D; Bidat N; Boudet J; Chaux R; Grange L; Barrau M; Gagneux-Brunon A; Cathébras P; Killian M; Botelho-Nevers E; Célarier T
Age Ageing; 2024 Apr; 53(4):. PubMed ID: 38619123
[TBL] [Abstract][Full Text] [Related]
4. Proton pump inhibitor use: systematic review of global trends and practices.
Shanika LGT; Reynolds A; Pattison S; Braund R
Eur J Clin Pharmacol; 2023 Sep; 79(9):1159-1172. PubMed ID: 37420019
[TBL] [Abstract][Full Text] [Related]
5. Proton pump inhibitors and the risk of acute kidney injury in cancer patients receiving immune checkpoint inhibitors: A Danish population-based cohort study.
Munch PV; Nørgaard M; Heide-Jørgensen U; Jensen SK; Birn H; Christiansen CF
Int J Cancer; 2024 Apr; 154(7):1164-1173. PubMed ID: 37983738
[TBL] [Abstract][Full Text] [Related]
6. Critique of "Risk of Gynecomastia with Users of Proton Pump Inhibitors".
Brown JD
Pharmacotherapy; 2019 Jul; 39(7):791. PubMed ID: 31063650
[No Abstract] [Full Text] [Related]
7. Alternative Viewpoint of "Risk of Gynecomastia with Users of Proton Pump Inhibitors".
Lai SW
Pharmacotherapy; 2019 Jul; 39(7):790. PubMed ID: 31067343
[No Abstract] [Full Text] [Related]
8. The drugs that mostly frequently induce gynecomastia: A national case - noncase study.
Batteux B; Llopis B; Muller C; Khouri C; Moragny J; Liabeuf S; Masmoudi K; Gras V;
Therapie; 2020; 75(3):225-238. PubMed ID: 31471065
[TBL] [Abstract][Full Text] [Related]
9. Drs. He et al. Reply to Drs. Lai and Brown.
He B; Carleton B; Etminan M
Pharmacotherapy; 2019 Jul; 39(7):792-793. PubMed ID: 31071231
[No Abstract] [Full Text] [Related]
10. Prepubertal gynecomastia is not always idiopathic: case series and review of the literature.
Laimon W; El-Hawary A; Aboelenin H; Elzohiri M; Abdelmaksoud S; Megahed N; Salem N
Eur J Pediatr; 2021 Mar; 180(3):977-982. PubMed ID: 32975593
[TBL] [Abstract][Full Text] [Related]
11. Effects of long-term proton pump inhibitor use on sexual hormones and sexual and reproductive health in female patients.
Ashfaq M; Khan Q; Haroon MZ; Abid SMA; Sharif MJH; Alkahraman YMSA
Endocrine; 2024 Feb; 83(2):494-501. PubMed ID: 37914918
[TBL] [Abstract][Full Text] [Related]
12. Incidental Gynecomastia on Thoracic Computed Tomography in Clinical Practice: Characteristics, Radiologic Features, and Correlation With Possible Causes in South Korean Men.
Kim MS; Kim JH; Lee KH; Suh YJ
Am J Mens Health; 2020; 14(3):1557988320908102. PubMed ID: 32456508
[TBL] [Abstract][Full Text] [Related]
13. Statin medications and the risk of gynecomastia.
Skeldon SC; Carleton B; Brophy JM; Sodhi M; Etminan M
Clin Endocrinol (Oxf); 2018 Oct; 89(4):470-473. PubMed ID: 29923212
[TBL] [Abstract][Full Text] [Related]
14. Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.
Lazarus B; Chen Y; Wilson FP; Sang Y; Chang AR; Coresh J; Grams ME
JAMA Intern Med; 2016 Feb; 176(2):238-46. PubMed ID: 26752337
[TBL] [Abstract][Full Text] [Related]
15. Comparative risk of ischemic stroke among users of clopidogrel together with individual proton pump inhibitors.
Leonard CE; Bilker WB; Brensinger CM; Flockhart DA; Freeman CP; Kasner SE; Kimmel SE; Hennessy S
Stroke; 2015 Mar; 46(3):722-31. PubMed ID: 25657176
[TBL] [Abstract][Full Text] [Related]
16. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
[TBL] [Abstract][Full Text] [Related]
17. The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.
Freedberg DE; Kim LS; Yang YX
Gastroenterology; 2017 Mar; 152(4):706-715. PubMed ID: 28257716
[TBL] [Abstract][Full Text] [Related]
18. Risk of Gynecomastia with Users of Proton Pump Inhibitors.
He B; Carleton B; Etminan M
Pharmacotherapy; 2019 May; 39(5):614-618. PubMed ID: 30865318
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
